Alzheimer’s drug cited as Medicare premium jumps by $21.60

December 3, 2021

Alzheimer’s drug cited as Medicare premium jumps by $21.60 By: Ricardo Alonso-zaldivar, The Associated Press
Posted: 4:10 PM CST Friday, Nov. 12, 2021
Last Modified: 8:44 PM CST Friday, Nov. 12, WASHINGTON (AP) — Medicare’s “Part B” outpatient premium will jump by $21.60 a month in 2022, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that. FILE – The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass.

Read the source article at Winnipeg Free Press
2021-11-13 02:44:02

Share This Story!